The microtubule stabilizing agent epothilone D has been shown to reduce pathological aggregation and phosphorylation of tau and lead to improvements in behavioral function in transgenic mouse models of human tauopathies [7, 10, 109]. This evidence concerns the gene MAPT and tauopathy.